Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

The cydy/incelldx honeymoon was on. Except along c

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72838
(Total Views: 774)
Posted On: 11/24/2020 12:31:40 AM
Posted By: blafarm
Quote:
The cydy/incelldx honeymoon was on. Except along comes the BLA and the FDA shoots down the Receptor occupancy tests.

I could be mistaken, but I believe the relationship between Dr.NP and Dr.BP might have become strained before the FDA issued the RTF. And it seems the FDA would only have been able to articulate their issues with the ROT in the context of the RTF.

Also, my impression is that the FDA's issues with the ROT were centered around consistency concerns across the patient population over time -- rather than necessarily a material defect with Dr.BP's ROT test. I seriously doubt IncellDX's ROT's are/were fundamentally defective. Of course, I could be mistaken on all counts.

Lastly, let's not forget that it was months later before we learned this incredibly important fact. We investors were initially spoon-fed an incomplete description of the scope of the RTF that included only two issues that were described as easily remedied because CytoDyn already had everything they needed to resubmit the BLA. More specifically, we were told about labeling issues relating to bundled 3rd party syringes and the need to include a CD-03 Mono Integrated Assessment.

I'd be willing to give CytoDyn the benefit of the doubt that maybe they did not learn of the FDA's rejection of the ROT until months after the issuance of the RTF. However, prior to the Type A meeting where they might have learned that fact, shareholders had already become quite vocal during conference calls asking why Dr.BP was no longer involved and why he was not being invited to participate in the Scientific Board of Advisors. When Dr.NP finally got around to telling us that all of the ROTs had to be re-run, he seemed to be using it to disparage or discredit Dr.BP -- in order to explain his absence from the company.

I think none of us are served by regurgitating the alleged friction between Dr.NP and Dr.BP. My only point is that if CytoDyn only learned of the ROT problem months after the RTF, then the thesis regarding it being the genesis of their failed relationship (which became apparent months earlier) becomes even more tenuous in terms of timing.

Enough said. It is certainly an unfortunate chapter, but we have much to look forward to.












(8)
(0)






CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  











Previous | Next

Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

© 2021 Copyright Investors Hangout, LLC All Rights Reserved.

Mobile |Privacy Policy | Terms & Conditions | Disclaimer | Help | Contact Us

Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use.NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.